Jon J. Snyder - Founder, President, and CEO.  Over 25 years of domestic and international management leadership experience in biomedical and healthcare sales, marketing,  operations, and venture capital investment at start-up and Fortune 500 (Top 20) companies including Cyberonics, Cardinal Health, Imalux, and STERIS Corporation. 

Zi-Ping Fang, Ph.D. - Chief Scientific Officer.  PhD in Biomedical Engineering focused on neurostimulation technology from Case Western Reserve University. Over 25 years of neurostimulation R&D, pre-clinical and clinical research leading to FDA approval, including technology leadership and management and executive responsibility in neurostimulation startup business development and operations including Nevro and NeuroControl.

Bob Centa - Chief Financial Officer.  Over 25 years of experience in finance, accounting, operations, human resources, IT, and M&A at public and privately held companies including Avalon Precision Casting, Weatherchem, Emerald Performance Materials and State Industrial Products.

Jan Dugas - Vice President, Clinical and Regulatory Affairs.  Over 25 years of leadership in medical device with an emphasis on neurostimulation and neuroblocking systems.  Has successfully led domestic and international initiatives for class III medical device startups and Fortune 1000 healthcare organizations resulting in multiple FDA and international product approvals, including Medtronic, St. Jude Medical, Respithera, EnteroMedics, Cardiovascular Systems, and Terumo Cardiovascular.

Management Team